OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2016
(4)
2022
(2)
2014
(2)
2013
(2)
2011
(2)
2021
(1)
2019
(1)
2015
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
Not available
S-EPMC9164098
|
biostudies-literature
Cite
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC4406179
|
biostudies-literature
Cite
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Not available
S-EPMC6880781
|
biostudies-literature
Cite
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Not available
S-EPMC8576477
|
biostudies-literature
Cite
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
Not available
S-EPMC9537519
|
biostudies-literature
Cite
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
Not available
S-EPMC4853421
|
biostudies-literature
Cite
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Not available
S-EPMC5023955
|
biostudies-literature
Cite
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
Not available
S-EPMC3510753
|
biostudies-literature
Cite
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3974638
|
biostudies-literature
Cite
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Not available
S-EPMC4630206
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets